NMTC · Company research

NeuroOne Medical Technologies Corporation (NMTC): Stock News & Events

Recent company-linked news records available in the database.

RESEARCH CONTEXT

Understand the numbers

Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.

16records availableHealthcare

Stock News & Events data

Database-backed records only

16 rows
titlesummaryurlsourcepublished atsentimentsentiment scorerelevance score
NeuroOne Medical Technologies Corporation (NMTC) Stock Price, News, Quote & History - Yahoo! Finance CanadaNeuroOne Medical Technologies Corporation (NMTC) Stock Price, News, Quote & History Yahoo! Finance CanadaView source ↗Yahoo! Finance CanadaOct 9, 2026neutral00.6
NeuroOne Medical (NMTC) Partners with Dartmouth College to Advan - GuruFocusNeuroOne Medical (NMTC) Partners with Dartmouth College to Advan GuruFocusView source ↗GuruFocusOct 8, 2026neutral00.6
A roughly $1 million NIH grant backs research to track brain chemicals in real time - Stock TitanA roughly $1 million NIH grant backs research to track brain chemicals in real time Stock TitanView source ↗Stock TitanOct 8, 2026neutral00.6
NeuroOne Reports Strong Fiscal 2026 Revenue Growth - The Globe and MailNeuroOne Reports Strong Fiscal 2026 Revenue Growth The Globe and MailView source ↗The Globe and MailOct 6, 2026neutral00.6
NeuroOne Medical Technologies (NasdaqCM:NMTC) Stock Forecast & Analyst Predictions - Simply Wall StreetNeuroOne Medical Technologies (NasdaqCM:NMTC) Stock Forecast & Analyst Predictions Simply Wall StreetView source ↗Simply Wall StreetOct 6, 2026neutral00.6
NeuroOne (NMTC) Secures Largest $4.5M Product Purchase Order, Bo - GuruFocusNeuroOne (NMTC) Secures Largest $4.5M Product Purchase Order, Bo GuruFocusView source ↗GuruFocusOct 5, 2026neutral00.6
NeuroOne NMTC Expects $3.8 Million Fiscal Q4 Product Revenue - Quiver QuantitativeNeuroOne NMTC Expects $3.8 Million Fiscal Q4 Product Revenue Quiver QuantitativeView source ↗Quiver QuantitativeOct 5, 2026neutral00.6
Fourth-quarter product revenue is expected to rise 38.4% to about $3.8 million. - Stock TitanFourth-quarter product revenue is expected to rise 38.4% to about $3.8 million. Stock TitanView source ↗Stock TitanOct 5, 2026neutral00.6
NMTC Q3 2026 Earnings: Wider-Than-Expected Loss Meets a 13.69% Stock Rally - Earnings Risk Report - dars.gov.etNMTC Q3 2026 Earnings: Wider-Than-Expected Loss Meets a 13.69% Stock Rally - Earnings Risk Report dars.gov.etView source ↗dars.gov.etOct 3, 2026neutral00.6
Neuroone Medical Technologies Corp (NMTC) Shareholding Pattern – Promoters, FIIs & DIIs - Value ResearchNeuroone Medical Technologies Corp (NMTC) Shareholding Pattern – Promoters, FIIs & DIIs Value ResearchView source ↗Value ResearchSep 16, 2026neutral00.6
$NMTC stock is up 10% today. Here's what we see in our data. - Quiver Quantitative$NMTC stock is up 10% today. Here's what we see in our data. Quiver QuantitativeView source ↗Quiver QuantitativeAug 27, 2026neutral00.6
NMTC Forecast — Price Target — Prediction for 2027 - TradingViewNMTC Forecast — Price Target — Prediction for 2027 TradingViewView source ↗TradingViewJun 25, 2026neutral00.6
NeuroOne(R) Medical Technologies Announces Reverse Stock Split to Regain Nasdaq Compliance - Yahoo FinanceNeuroOne(R) Medical Technologies Announces Reverse Stock Split to Regain Nasdaq Compliance Yahoo FinanceView source ↗Yahoo FinanceApr 14, 2026neutral00.6
Bullish NeuroOne Medical Technologies Insiders Rewarded As Their Investment Rises To US$829.9k - Simply Wall StreetBullish NeuroOne Medical Technologies Insiders Rewarded As Their Investment Rises To US$829.9k Simply Wall StreetView source ↗Simply Wall StreetApr 7, 2026neutral00.6
Should I buy NeuroOne Medical Technologies Corporation (NMTC) - Zacks Investment ResearchShould I buy NeuroOne Medical Technologies Corporation (NMTC) Zacks Investment ResearchView source ↗Zacks Investment ResearchJan 6, 2026neutral00.6
symbol__ Stock Quote Price and Forecast - CNNsymbol__ Stock Quote Price and Forecast CNNView source ↗CNNMar 26, 2024neutral00.6

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.